VC
TMO icon

Veracity Capital’s Thermo Fisher Scientific TMO Stock Holding History

Veracity Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Sell
406
-34
-8% -$16.3K 0.05% 216
2026
Q1 		$216K Sell
440
-513
-54% -$278K 0.08% 191
2025
Q4 		$552K Sell
953
-200
-17% -$113K 0.16% 124
2025
Q3 		$559K Buy
+1,153
New +$537K 0.18% 125
2025
Q2 		– Sell
-436
Closed -$217K – 252
2025
Q1 		$217K Buy
+436
New +$236K 0.08% 212
2024
Q4 		– Sell
-559
Closed -$346K – 234
2024
Q3 		$346K Sell
559
-5
-0.9% -$2.96K 0.13% 152
2024
Q2 		$312K Sell
564
-173
-23% -$99.1K 0.13% 149
2024
Q1 		$428K Buy
737
+123
+20% +$69K 0.17% 135
2023
Q4 		$326K Sell
614
-75
-11% -$36.3K 0.13% 145
2023
Q3 		$349K Buy
689
+8
+1% +$4.26K 0.16% 128
2023
Q2 		$355K Buy
681
+47
+7% +$25.4K 0.15% 142
2023
Q1 		$365K Sell
634
-35
-5% -$19.7K 0.17% 134
2022
Q4 		$369K Sell
669
-30
-4% -$15.9K 0.18% 124
2022
Q3 		$355K Sell
699
-26
-4% -$14.6K 0.19% 116
2022
Q2 		$394K Sell
725
-172
-19% -$94.7K 0.21% 113
2022
Q1 		$530K Sell
897
-923
-51% -$530K 0.22% 105
2021
Q4 		$1.22M Sell
1,820
-310
-15% -$194K 0.49% 51
2021
Q3 		$1.22M Sell
2,130
-202
-9% -$111K 0.52% 48
2021
Q2 		$1.18M Sell
2,332
-2,764
-54% -$1.3M 0.27% 80
2021
Q1 		$2.33M Buy
5,096
+264
+5% +$126K 0.5% 51
2020
Q4 		$2.25M Buy
4,832
+3,410
+240% +$1.6M 0.56% 57
2020
Q3 		$628K Buy
+1,422
New +$587K 0.17% 150
2020
Q2 		– Sell
-999
Closed -$283K – 283
2020
Q1 		$283K Buy
999
+114
+13% +$35.9K 0.08% 153
2019
Q4 		$287K Buy
+885
New +$268K 0.07% 184

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Veracity Capital's TMO Position: Q2 2026 in Review

Veracity Capital reduced its Thermo Fisher Scientific (TMO) stake by 7.7% in Q2 2026, selling an estimated $16.3K and leaving 406 shares worth $203K. The position accounts for 0.05% of the portfolio, ranked #216.

Veracity Capital first reported a position in TMO in Q4 2019 and has held it in 24 quarters since. The position peaked at $2.33M in Q1 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Veracity Capital held 406 shares of Thermo Fisher Scientific worth $203K as of Q2 2026.
  • Veracity Capital sold 34 Thermo Fisher Scientific shares in Q2 2026, an estimated $16.3K.
  • Thermo Fisher Scientific made up 0.05% of Veracity Capital's portfolio in Q2 2026, its #216 holding.
  • Veracity Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 24 quarters since.
  • Veracity Capital's Thermo Fisher Scientific position peaked at $2.33M in Q1 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Veracity Capital's 13F filing for Q2 2026, filed 13 Jul 2026.